Cyanocobalamin for vitamin b 12 deficiency

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Aug 2021: Trial registered, NCT05005897
  2. 8 Dec 2021: Trial started, NCT05005897

The trials

NCT05005897: Early Infant Micronutrition and Development

State
Under way
Phase
Phase 2 and Phase 3
People
600 planned
Started
8 Dec 2021
Primary completion
15 Oct 2025
Arms
Screening - treatment
Results
None posted
  1. 16 Aug 2021: Trial registered
  2. 8 Dec 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Also known as Berubigen, BETALIN 12, Calomist, Cobavite, Cyomin, Nascobal, Redisol, Rubivite, Rubramin, Rubramin pc, Ruvite, Vi-twel, Vibisone.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.